Latest Form 4 insider transactions

Paul Cahill Sciarra, a Director of Joby Aviation, Inc., received 2,773 shares of common stock on October 5, 2026.

Michael N. Thompson Jr., a Director of Joby Aviation, Inc., received 2,971 shares of common stock on October 5, 2026.

Gregory Bowles, Chief Policy Officer of Joby Aviation, Inc., sold 5,302 shares of common stock on October 5, 2026 for $5.78 per share.

Tetsuo Ogawa, a Director of Joby Aviation, Inc., received 2,773 shares of common stock on October 5, 2026.

Aaron Zell, a Director of Par Pacific Holdings, Inc., received 314 shares of common stock on October 5, 2026.

Dipender Saluja, a Director of Joby Aviation, Inc., received 2,971 shares of common stock on October 5, 2026.

Personalis, Inc. announced the expiration of the HSR waiting period for its proposed merger with Tempus AI, Inc., marking a step forward in the transaction process.

Vivek Narayanadas, General Counsel & Secretary of Oklo Inc., sold 649 shares of common stock on October 3, 2026 for $35.93 per share.

John Anthony Dibella Ii, Chief Revenue Officer of Simulations Plus, Inc., reported multiple transactions in common stock on October 6, 2026.

Yaaqov Mann, Chief Technology Officer of Kornit Digital Ltd., sold 97,066 shares of common stock on October 2, 2026.

Sharlene Evans, a Director of Simulations Plus, Inc., reported a transaction in 17,173 shares of common stock on October 6, 2026.

Jill Fiedler-Kelly, President, Services Solutions of Simulations Plus, Inc., reported multiple transactions in common stock on October 6, 2026.

William W Frederick, EVP/CFO of Simulations Plus, Inc., reported multiple transactions in common stock on October 6, 2026.

John Kenneth Paglia, a Director of Simulations Plus, Inc., reported multiple transactions in common stock on October 6, 2026.

Michael P Dube, VP, Chief Accounting Officer of Intellia Therapeutics, Inc., sold 1,864 shares of common stock on October 2, 2026 for $12.43 per share.

Matthew Bowen, Principal Accounting Officer of Monte Rosa Therapeutics, Inc., sold 13 shares of common stock on October 5, 2026 for $10.56 per share.

Daniel L Weiner, a Director of Simulations Plus, Inc., reported multiple transactions in common stock on October 6, 2026.

Eric Stokes, SVP and Group President of WTS of Northwest Pipe Co, sold 12,631 shares of common stock on October 2, 2026 for $105.86 per share.

Tyler Sloat, a Director of Hinge Health, Inc., received 175 shares of common stock on October 5, 2026.

Neil Glat, a Director of Evolv Technologies Holdings, Inc., reported multiple transactions in common stock on July 16, 2026.

Melissa A Burgum, Chief Accounting Officer of Accenture plc, received 101 shares of common stock on October 5, 2026.

Angie Y Park, Chief Financial Officer of Accenture plc, received 140 shares of common stock on October 5, 2026.

Julie Spellman Sweet, Chair and CEO and a Director of Accenture plc, received 197 shares of common stock on October 5, 2026.

Catherine Kiernan Hogan, Chief Operating Officer of Accenture plc, received 109 shares of common stock on October 5, 2026.

Joel Unruch, General Counsel/Corp Secretary of Accenture plc, received 140 shares of common stock on October 5, 2026.

Katherine Lee Clifford, Chief Leadership & HR Officer of Accenture plc, received 89 shares of common stock on October 5, 2026.

Walter S Woltosz and 1 other reported changes in beneficial ownership of Simulations Plus, Inc. common stock on October 6, 2026.

Manish Sharma, Chief Strategy & Services Ofcr of Accenture plc, received 93 shares of common stock on October 5, 2026.

John F Walsh, CEO-The Americas of Accenture plc, received 139 shares of common stock on October 5, 2026.

Kevin M. Charlton, a Director of Evolv Technologies Holdings, Inc., reported a transaction in 67,500 shares of common stock on July 16, 2026.